Blueprint Medicines Corp (NASDAQ: BPMC) Could Achieve Gains In The Near Future

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Blueprint Medicines Corp is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Blueprint Medicines Corp is $5.76B. A total of 0.93 million shares were traded on the day, compared to an average of 629.08K shares.

In the most recent transaction, Albers Jeffrey W. sold 15,000 shares of BPMC for 89.77 per share on Dec 19 ’24. After the transaction, the Director now owns 157,557 company shares. In a previous transaction on Dec 18 ’24, Rossi Christina sold 2,274 shares at 95.91 per share. BPMC shares that CHIEF OPERATING OFFICER owns now total 69,383.

Among the insiders who bought shares, Albers Jeffrey W. acquired of 15,000 shares on Dec 19 ’24 at a per-share price of $89.78. In another insider transaction, Hurley Ariel sold 1,819 shares at $93.26 per share on Dec 12 ’24. Company shares held by the PRINCIPAL ACCOUNTING OFFICER now total 14,967.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BPMC has a high of $121.90 and a low of $72.24.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BPMC’s latest balance sheet shows that the firm has $477.11M in Cash & Short Term Investments as of fiscal 2021. There were $111.41M in debt and $149.76M in liabilities at the time. Its Book Value Per Share was $4.93, while its Total Shareholder’s Equity was $970.74M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BPMC is Buy with a score of 4.25.

Most Popular

Related Posts